MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cam4.71127

Медицинская библиотека · Cancer medicine · 2025

Impact of Pre-Treatment Serum Ferritin on Response and Survival in Myelodysplastic Syndromes Treated With Azacytidine: A Multivariate Analysis.

Carrasco Gloria Moreno, Flores Rodolfo Matias Ortiz, Delgado Regina García, Morcillo Borja Cidoncha, Rosell Mas Ana Isabel, Díaz Canales Dana, González María Rodríguez, Gomariz Manuel Carrasco, Escamilla-Sánchez Alejandro

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Myelodysplastic syndromes (MDS) encompass a heterogeneous group of haematological neoplasms characterized by ineffective haematopoiesis and a variable risk of transformation to acute myeloid leukaemia (AML). Elevated serum ferritin (SF), a marker of iron overload (IO), has been linked to poorer outcomes in MDS. However, the impact of pre-treatment SF levels on azacytidine (AZA) response and survival outcomes remains unclear.

METHODS

This retrospective cohort study included patients with World Health Organization-defined MDS or AML with 20%-30% bone marrow blasts treated with AZA at the Virgen de la Victoria University Hospital (Málaga, Spain) from 2007 onwards. Patients were stratified into three groups based on pre-treatment SF levels: < 500 ng/mL, 500-1000 ng/mL and > 1000 ng/mL. Logistic regression and Kaplan-Meier methods were used to analyse overall response (OR) and overall survival (OS).

RESULTS

Among 240 patients, 190 with available SF data were analysed. Patients with SF > 1000 ng/mL showed significantly lower OR (24.2%) and shorter OS (median: 10.1 months) compared to those with SF < 500 ng/mL (OR: 71.4%, OS: 18.2 months) and 500-1000 ng/mL (OR: 82.6%, OS: 20.5 months) (p < 0.0001 for OR, p = 0.001 for OS). Multivariate analysis confirmed elevated SF as an independent predictor of poorer outcomes.

CONCLUSIONS

Elevated pre-treatment SF levels are strongly associated with reduced response and survival in patients with MDS or AML treated with AZA. Early IO management, such as iron chelation, may improve treatment outcomes.

Для цитирования: Carrasco Gloria Moreno, Flores Rodolfo Matias Ortiz, Delgado Regina García, Morcillo Borja Cidoncha, Rosell Mas Ana Isabel, Díaz Canales Dana, González María Rodríguez, Gomariz Manuel Carrasco, Escamilla-Sánchez Alejandro. Impact of Pre-Treatment Serum Ferritin on Response and Survival in Myelodysplastic Syndromes Treated With Azacytidine: A Multivariate Analysis.. Cancer medicine. 2025. DOI: 10.1002/cam4.71127.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.